TA-backed nutraceuticals maker OmniActive explores $300-M IPO at $1-B valuation

Mumbai-headquartered dietary supplements, food, and drink maker OmniActive Health Technologies is in talks with bankers to explore an initial public offering (IPO) aiming to raise between USD 200-M and USD 300-M. The proposed transaction is expected to value the company at about USD 1-B and may involve a combination of fresh capital issuance and an offer for sale by its majority investor, TA Associates, and the promoter group.Founded in 2005 by Sanjay Mariwala and Hiren Doshi, the company manufactures natural ingredients for use in health supplements, fortified foods, and beverages. The firm maintains operations in India, the Netherlands, and New Jersey (USA). As of September 2025, TA Associates held a 56% stake in the company, with the Mariwala family owning 40% and other shareholders holding the remaining interest. The company reported an operating income of INR 886-Cr for FY25, up from INR 837-Cr in the previous year, with an adjusted profit of INR 165-Cr.